Role of pharmacological factors in the evaluation of anticonvulsant drugs.
D000136:Acid-Base Equilibrium; D000367:Age Factors; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology / Q000592:standards / Q000627:therapeutic use; D001831:Body Temperature; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D004357:Drug Synergism; D004777:Environment; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007456:Iodine Isotopes; D008722:Methods; D009748:Nutrition Disorders; D010672:Phenytoin / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology / Q000592:standards; D051381:Rats; D011955:Receptors, Drug; D012640:Seizures / Q000201:enzymology; D013328:Strophanthins / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects; D013997:Time Factors; D014882:Water-Electrolyte Balance
D000927:Anticonvulsants; D007456:Iodine Isotopes; D011955:Receptors, Drug; D013328:Strophanthins; D010672:Phenytoin